Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 2.100
+0.070 (3.45%)
At close: Apr 17, 2026
Pentixapharm Holding AG Revenue
In the year 2025, Pentixapharm Holding AG had annual revenue of 526.00K EUR, down -74.37%. Pentixapharm Holding AG had revenue of 409.00K in the quarter ending December 31, 2025, a decrease of -80.07%.
Revenue
526.00K
Revenue Growth
-74.37%
P/S Ratio
98.94
Revenue / Employee
8.62K
Employees
61
Market Cap
52.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 526.00K | -1.53M | -74.37% |
| Jan 1, 2025 | 2.05M | -4.46M | -68.49% |
| Dec 31, 2023 | 6.51M | 2.54M | 64.04% |
| Dec 31, 2022 | 3.97M | 1.37M | 52.67% |
| Dec 31, 2021 | 2.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Merck KGaA | 21.10B |
| Maternus-Kliniken Aktiengesellschaft | 116.17M |
| FamiCord AG | 88.29M |
| DocCheck AG | 56.60M |
| MeVis Medical Solutions AG | 16.06M |